Biosimilars for the Treatment of Rheumatoid Arthritis

Biosimilars and used to treat Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis.

Biosimilars are appoved by the FDA and Health Canada for safety and efficacy.

Biosimilars will potentially be less expensive than the original Biologics.

Unlike Biologics, Biosimilars are taken orally.

Patients taking Biosimilars can expect the same range of services and financial assistance as the original Biologics offer.